Sun Pharma Q4 results 2026: Profit jumped 26% YoY to ₹2,714 crore. Total revenue from operations for the quarter under review rose 12.8% YoY to ₹14,611.79 crore. Sun Pharma's board recommended a final dividend of ₹5 per share of ₹l each.
Market Samachar is a news aggregator. This article was originally published by mint - markets. Tap the button above to read the full story on their site.
Trade NSE stocks with virtual coins. Build a portfolio, climb the leaderboard — zero real money.
1,500+ Indian market quiz questions. Earn coins per correct answer, climb leagues, build streaks.
Live gainers · losers · FII/DII · MTF · News Buzz. The complete Indian market dashboard.
Swipe BULL or BEAR on today's news. Earn +5 coins per swipe, +20 bonus when you're right.